Osmotica Pharmaceuticals plc (OSMT) Prices 5M Share Common Offering at $6.55/Sh

Go back to Osmotica Pharmaceuticals plc (OSMT) Prices 5M Share Common Offering at $6.55/Sh

After-Hours Stock Movers 07/13: (INMB) (VNDA) (FREQ) Higher; (OSMT) (MHK) (ALT) Lower (more...)

July 13, 2020 5:35 PM EDT

Today's After-Hours Stock Movers:

INmune Bio, Inc. (NASDAQ: INMB) 68.9% HIGHER; today reported clinical data demonstrating that its lead drug candidate, XPro1595, decreases neuroinflammation in patients with Alzheimers disease. Interim results from a Phase Ib clinical trial show that treatment with XPro1595 decreases white matter free water, a biomarker of neuroinflammation measured by MRI. XPro1595 is a next-generation inhibitor of tumor necrosis factor (TNF) that selectively neutralizes soluble TNF, an inflammatory cytokine implicated in Alzheimer's pathology, without affecting transmembrane TNF or the TNF receptors.

Osmotica Pharmaceuticals plc (Nasdaq:... More

Osmotica Pharmaceuticals (OSMT) Announces 5M Share Proposed Public Offering of Ordinary Shares

July 13, 2020 4:15 PM EDT

Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (Osmotica or the Company), a fully integrated biopharmaceutical company, announced today the commencement of a proposed public offering of 5,000,000 ordinary shares. All of the shares will be offered by Osmotica. Osmotica also expects to grant the underwriters a... More

Osmotica Pharmaceuticals plc (OSMT) Adds to Gains Following FDA Approval

July 10, 2020 11:25 AM EDT

Osmotica Pharmaceuticals plc (NASDAQ: OSMT) sees continued momentum following FDA approval of Upneeq on Thursday; shares up 18%.

... More